Novel dihydroquinoline-based MABAs; clues to the identity of LAS-190792: evaluation of WO20111411802

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 2, 2012-02 ,pp. : 185-192

Informa Healthcare

Access to resources Recommend Favorite

AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 11, 2009-11 ,pp. : 1629-1633

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of WO2012032067 and WO2012055846: two selective PI3Kδ inhibitors, which is GSK-2269557?

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 965-970

Informa Healthcare

Access to resources Recommend Favorite

Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. : 1137-1142

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of WO2013136076: two crystalline forms of the phosphatidylinositol 3-kinase-δ inhibitor RV-1729

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2013-04 ,pp. : 471-475

Informa Healthcare

Access to resources Recommend Favorite